01—History
Free Cash Flow History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $1.04B
2 older moves run past ±150% (largest +4362.0%); point at, tap or drag across the bars to read one.
02—Ledger
Free Cash Flow, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $1.04B | −3.7% | 10-K | |
| FY2024 | $1.08B | +44.5% | 10-K | |
| FY2023 | $747.6M | +12.6% | 10-K | |
| FY2022 | $663.7M | +39.0% | 10-K | |
| FY2021 | $477.4M | −31.4% | 10-K | |
| FY2020 | $696.4M | +339.9% | 10-K | |
| FY2019 | −$290.3M | −148.9% | 10-K | |
| FY2018 | $594.0M | +53.1% | 10-K | |
| FY2017 | $387.9M | −35.9% | 10-K | |
| FY2016 | $605.6M | +81.9% | 10-K | |
| FY2015 | $333.0M | +8.2% | 10-K | |
| FY2014 | $307.9M | −21.7% | 10-K | |
| FY2013 | $393.4M | +85.8% | 10-K | |
| FY2012 | $211.7M | −1.2% | 10-K | |
| FY2011 | $214.2M | +11.1% | 10-K | |
| FY2010 | $192.9M | +4362.0% | 10-K | |
| FY2009 | $4.3M | +102.6% | 10-K | |
| FY2008 | −$164.8M | — | 10-K |
03—Questions
What is United Therapeutics's current free cash flow?
United Therapeutics (UTHR) annual free cash flow for 2025 was $1.04B, a 3.69% decline from 2024. United Therapeutics free cash flow for the quarter ending September 30, 2026 was $125.8M.
What was United Therapeutics's free cash flow in 2024?
United Therapeutics annual free cash flow for 2024 was $1.08B, a 44.54% increase from 2023.
What was United Therapeutics's free cash flow in 2023?
United Therapeutics annual free cash flow for 2023 was $747.6M, a 12.64% increase from 2022.
What is United Therapeutics's 5-year free cash flow CAGR?
United Therapeutics free cash flow grew at a compound annual growth rate (CAGR) of 8.37% from FY2020 to FY2025, going from $696.4M to $1.04B over 5 years.
- Company
- United Therapeutics
- Ticker
- UTHR
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations